TICKERNERD
Menu
CONCONHealthcare · Medical Care Facilities

CON Stock Forecast: Concentra Group Holdings Parent, Inc. Price Predictions for 2026-2027

Last close, 3 Sept 2026
$35
+1.41% on the day

The 9 Wall Street analysts covering Concentra Group Holdings Parent, Inc. hold a median 12-month price target of $40 — +15.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 96 of 100 as at 2 Sept 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$4.3B
Ticker Nerd rank
96 / 100
Median analyst target
$40
Analysts covering
9
Revenue$606.0M+10.0% y/y
Operating income$115.1M
Net income$67.3M
Free cash flow$119.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−0.5%
1M
+9.1%
YTD
+76.6%
1Y
+47.2%
From 52W high
−2.7%
From 52W low
+86.3%
$19
$35
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CON stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Concentra Group Holdings Parent, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 2 Sept 2026
96 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
99
Momentum
94
Issuance
86
Growth
85
Value
68
Volatility
62
Quality
58
Accruals
57
Size
26

Revisions (99): Analysts have, on balance, been raising their forecasts.

Accruals (57): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (26): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CON stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CON, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$20$25$30$35$40Oct 25Jan 26Apr 26Jul 26CONHigh $42Median $40Low $34

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says9 analysts
9 Buy0 Hold0 Sell
Low $34Median $40High $42

The green dot is the last close — the median target sits +15.9% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 4 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
11 Aug 2026Wells FargoMaintainsOverweight$28 → $40
10 Aug 2026RBC CapitalMaintainsOutperform$36 → $42
10 Aug 2026Truist SecuritiesMaintainsBuy$37 → $42
14 July 2026Truist SecuritiesMaintainsBuy—
14 July 2026Truist SecuritiesMaintainsBuy$31 → $37
1 July 2026William BlairInitiatesOutperform—
1 July 2026William BlairInitiatesOutperform—
5 June 2026Goldman SachsInitiatesBuy—
11 May 2026Truist SecuritiesReiteratesBuy—
5 Mar 2026Wells FargoMaintainsOverweight—
2 Feb 2026RBC CapitalMaintainsOutperform—
18 Sept 2025JP MorganAssumesOverweight$31
19 Mar 2025JP MorganMaintainsOverweight—
12 Mar 2025Wells FargoMaintainsOverweight—
23 Jan 2025B of A SecuritiesMaintainsBuy—
23 Jan 2025RBC CapitalReiteratesOutperform—
16 Dec 2024B of A SecuritiesUpgradeBuy—
4 Nov 2024RBC CapitalMaintainsOutperform—
7 Oct 2024B of A SecuritiesDowngradeNeutral—
20 Aug 2024RBC CapitalInitiatesOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CON appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

CON vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 3 Sept 2026, Concentra Group Holdings Parent, Inc. returned +47.2% against +21.4% for the S&P 500, dividends included.

CON vs S&P 500, last 12 monthsTotal return, rebased to 100
80100120140160Oct 25Jan 26Apr 26Jul 26CONS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CON analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+7.6%
Analysts raising
1
Analysts cutting
0
Fundamentals

Concentra Group Holdings Parent, Inc. (CON) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
22.0×

Cheaper than 35% of US stocks

Price / sales
1.9×

Cheaper than 54% of US stocks

Price / book
9.1×

Cheaper than 11% of US stocks

EV / EBITDA
13.7×

Cheaper than 26% of US stocks

Growth & margins
Revenue growth (YoY)
10.0%

Higher than 52% of US stocks

Earnings growth (YoY)
46.5%

Higher than 73% of US stocks

Gross margin
31.7%

Higher than 37% of US stocks

Operating margin
19.3%

Higher than 78% of US stocks

Net margin
8.7%

Higher than 67% of US stocks

Returns & dividend
Return on equity
47.1%

Higher than 92% of US stocks

Return on assets
8.2%

Higher than 88% of US stocks

Dividend yield
0.7%

Higher than 15% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Concentra Group Holdings Parent, Inc. (CON) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Concentra Group Holdings Parent, Inc. has a market value of $4.3B and an enterprise value of $6.3B.

  • Revenue in the twelve months to 30 June 2026: $2.3B. The latest quarter grew 10.0% year on year.

  • Net income over the same four quarters: $205.6M, a 9.0% net margin.

  • Diluted earnings per share, trailing twelve months: $1.55.

  • Free cash flow in the twelve months to 30 June 2026: $267.4M.

  • Concentra Group Holdings Parent, Inc. spent $32.1M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 128.0M.

  • Trailing P/E: 22.0×; forward P/E: 18.6× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.74%, paying out 16% of earnings.

  • Concentra Group Holdings Parent, Inc. employs 9,967 people — $230K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 2 Sept 2026

Data provided by Twelve Data

Peers

CON vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
CONConcentra Group Holdings Parent, Inc.$4.3B
96
LFSTLifestance Health Group, Inc.$5.0B
93
OPCHOption Care Health, Inc.$3.7B
85
NHCNational HealthCare Corp.$3.4B
66
AVAHAveanna Healthcare Holdings, Inc.$2.9B
87
BKDBrookdale Senior Living, Inc.$2.8B
78
PACSPACS Group, Inc.$6.7B
88

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Concentra Group Holdings Parent, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CON news & analysis

3 Stocks to Add to Your Portfolio After Recent Broker Rating Upgrades

Zacks Investment Research · 3 Sept 2026positive

Zacks Investment Research highlighted Concentra Group as one of three stocks that have received recent broker rating upgrades while also showing strong projected earnings growth. The piece suggests these upgrades make the companies worth considering for investors.

Why it matters — A broker rating upgrade for CON indicates improving analyst sentiment toward the company, which watchers would take as a positive signal about its outlook.

CON vs. MEDP: Which Stock Should Value Investors Buy Now?

Zacks Investment Research · 26 Aug 2026neutral

Zacks Investment Research published a comparison of Concentra Group (CON) and Medpace (MEDP), asking which of the two medical services stocks offers the better value opportunity for investors at present.

Why it matters — The piece positions CON against a peer in the medical services sector, which could influence how value investors assess the stock.

Concentra Group (CON) is a Great Momentum Stock: Should You Buy?

Zacks Investment Research · 19 Aug 2026positive

Zacks Investment Research published an article examining whether Concentra Group (CON) qualifies as a top stock pick for momentum investors, evaluating the company's momentum characteristics.

Why it matters — A CON watcher would care because the article assesses whether the stock has the momentum profile that could attract investor attention.

Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health

Business Wire · 18 Aug 2026positive

Concentra announced that Dr. Jill Rosenthal, MD, MPH, will join the company on Sept. 1 and become chief medical officer effective Jan. 1, 2027. She previously served in physician leadership roles at the company, including area medical director, and will lead its national clinical strategy and physician leadership.

Why it matters — A CON watcher would care because a returning, nationally recognized occupational medicine leader taking over clinical strategy could shape the company's clinical innovation and workforce health direction.

Concentra Strengthens Workforce Health Access in Minnesota Through Acquisition

Business Wire · 17 Aug 2026positive

Concentra announced it has completed its acquisition of four Minnesota Occupational Health (MOH) medical centers in the Twin Cities. The acquisition aims to strengthen access to specialized occupational health care for Minnesota employees and connect local care teams with Concentra's national clinical and operational resources, effective August 17.

Why it matters — A CON watcher would care because the acquisition expands Concentra's occupational health footprint and market presence in Minnesota.

FAQ

Frequently asked questions about CON stock

What is the CON stock price forecast for 2026-2027?

The 9 Wall Street analysts covering Concentra Group Holdings Parent, Inc. have a median 12-month price target of $40, with estimates ranging from $34 to $42. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CON stock a buy right now?

Of the 9 analysts covering Concentra Group Holdings Parent, Inc., 9 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Concentra Group Holdings Parent, Inc. 96 out of 100 across roughly 4,600 US stocks as at 2 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CON?

As at 2 Sept 2026, Concentra Group Holdings Parent, Inc. ranks 96 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (99 of 100).

Will CON stock go up?

No one can know that. What the data says: the median 12-month target from 9 analysts implies +15.9% from the last close, and Ticker Nerd's factor model ranks Concentra Group Holdings Parent, Inc. 96 out of 100 as at 2 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CON stock forecast for 2030?

No analyst covering Concentra Group Holdings Parent, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CON are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $34 to $42 over the next 12 months.

How has CON stock performed over the past year?

Concentra Group Holdings Parent, Inc. returned +47.2% over the 12 months to 3 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Concentra Group Holdings Parent, Inc. do?

Concentra Group Holdings Parent, Inc. is a healthcare services company focused on occupational health in the United States.

What is the latest news on CON?

The most recent item we track (Zacks Investment Research, 3 Sept 2026): "3 Stocks to Add to Your Portfolio After Recent Broker Rating Upgrades". Zacks Investment Research highlighted Concentra Group as one of three stocks that have received recent broker rating upgrades while also showing strong projected earnings growth. The piece suggests these upgrades make the companies worth considering for investors.

Company

About Concentra Group Holdings Parent, Inc.

Concentra Group Holdings Parent, Inc. is a healthcare services company focused on occupational health in the United States. It provides workplace-oriented medical care through occupational health centers, onsite health clinics, and complementary service lines designed to support employers and working populations. Its offerings include workers’ compensation injury care, urgent care, clinical testing, preventive care, employer-sponsored primary care, telemedicine for work-related injuries and illnesses, pharmacy services, and medical compliance administration. Concentra Group Holdings Parent, Inc. serves businesses across industries that rely on employee health and safety programs, helping manage care delivered at employer worksites and through its network of health centers. The company is headquartered in Addison, Texas.

CEO Mr. William Keith Newton · 9,967 employees · United States · https://www.concentra.com